View in Browser 
Registered Nurses' Association of Ontario      

 

Statement on the Use of Hydroxychloroquine and Azithromycin for COVID-19 Prophylaxis 

As front-line health-care professionals, you may be aware that there has been significant mention in both social media and on the internet on the use of certain anti-malarial, antibiotic and antiviral therapies in the treatment of COVID-19 patients. Notwithstanding the widespread hope that a cure or treatment for COVID-19 symptoms is found quickly, Ontarians have an expectation and confidence that their health team members – physicians, nurse practitioners and pharmacists – are and will continue to work together to ensure that prescribing and dispensing of medications for the treatment of this deadly virus is evidence-based and with ultimate safety in mind.

Please read the statement.

 

Follow us
  Follow us on Instagram 

You have received this email because you indicated you want to receive information about this mailing list.

If you no longer wish to receive emails about this mailing list, please update your email preferences below:

Registered Nurses’ Association of Ontario (RNAO)
158 Pearl Street, Toronto, ON M5H 1L3.
Copyright 2020
All rights reserved